EN
HI
Zydus Lifesciences share price chart
Zydus Lifesciences Share Key Metrics
Volume
12.41 L
Market Cap
115082.98 CR
LTQ@LTP
2@1143.70
ATP
1141.34
Var Margin
12.85 %
Circuit Range
1029.4-1258
Delivery %
52.7 %
Value
141.59 CR
ASM/GSM
No
Market Lot
1
Summary
ZYDUSLIFE stock price is ₹1143.7 as of 19 Jul, 2026. The stock intraday movement has stayed between ₹1134.80 and ₹1156.70, while Zydus Lifesciences share price 52 week high low is ₹835.50 & ₹1181.50.
In terms of trading activity, ZYDUSLIFE share price has recorded a volume of 12,40,517 shares. The Zydus Lifesciences has a market cap of ₹1006233990. The stock’s Average Traded Price (ATP) stands at ₹1141.34, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 2 @ ₹1143.70.
The Zydus Lifesciences upper circuit limit is ₹1258.00 & The Zydus Lifesciences lower circuit limit is ₹1029.40, with a Value of ₹141.59 CR. The Delivery Percentage for the day is 52.7%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Zydus Lifesciences Fundamentals
P/E Ratio
22.62
P/B Ratio
4.38
Div. Yield
0.09
Sector P/E
69.58
Sector P/B
3.24
Sec. Div. Yield
0.53
Zydus Lifesciences Resistance and Support
Pivot 1155.07
Resistance
First Resistance
1164.14
Second Resistance
1174.37
Third Resistance
1183.44
Support
First Support
1144.84
Second Support
1135.77
Third Support
1125.54
Zydus Lifesciences Futures & Options
Zydus Lifesciences Option Chain
View Price, OI, Greeks & More...
28JUL26
1143.00
-12.00 (1.04%)
25AUG26
1150.00
-13.00 (1.12%)
29SEP26
1150.00
-23.00 (1.96%)
ZYDUSLIFE|28JUL26 CE 1140.00
20.95
-9.45 (-31.09%)
ZYDUSLIFE|28JUL26 PE 1150.00
23.55
4.6 (24.27%)
Zydus Lifesciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-19 | Audited Results |
| 2026-02-09 | Quarterly Results |
| 2025-11-06 | Quarterly Results & Fund raising |
| 2025-08-12 | Quarterly Results |
| 2025-05-20 | Audited Results & Final Dividend |
| 2025-02-05 | Quarterly Results |
| 2024-11-12 | Quarterly Results |
Zydus Lifesciences News
Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus Lifesciences has partnered with Apollo Hospitals via an MoU to expand the availability of the Shield™ Multi-Cancer Detection (MCD) test in India. This collaboration aims to enhance early diagnosis for multiple cancer types, leveraging Guardant Health's advanced blood test technology.
Jul 03 2026 12:16:59
Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
Zydus Lifesciences extended the closing date for its acquisition of Sterling Biotech's API business to September 30, 2026. This marks a second extension, indicating ongoing fulfillment of conditions precedent.
Jun 29 2026 14:36:17
Read More
Zydus Lifesciences Management
| Name | Position |
|---|---|
| Dhaval N Soni | Company Secretary & Compliance Officer |
| Pankaj R Patel | Chairman |
Zydus Lifesciences FAQs
The Buying Price of Zydus Lifesciences share is 1143.7 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Zydus Lifesciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Zydus Lifesciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Zydus Lifesciences shares is 22.62. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Zydus Lifesciences shares is 4.38. Useful to assess the stock's value relative to its book value.
To assess Zydus Lifesciences’s valuation compare Sector P/E, P/B which are 69.58 & 3.24 with sector averages, along with growth rates and financial metrics.
The Market Cap of Zydus Lifesciences is 115082.98 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Zydus Lifesciences share price is 1181.50 & 835.50. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Zydus Lifesciences belongs to the Healthcare sector.
Open a FREE Demat Account in 5 Mins.
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
